Progyny (NASDAQ: PGNY) reported Q1 EPS of $0.50, $0.24 better than the analyst estimate of $0.26. Revenue for the quarter came in at $328.5 million versus the consensus estimate of $326.57 million.

GUIDANCE:

Progyny sees FY2026 EPS of $1.98-$2.09, versus the consensus of $1.93. Progyny sees FY2026 revenue of $1.36-1.4 billion, versus the consensus of $1.5 billion.

Progyny sees Q2 2026 EPS of $0.50-$0.53, versus the consensus of $0.52. Progyny sees Q2 2026 revenue of $342-355 million, versus the consensus of $346.3 million.

For earnings history and earnings-related data on Progyny (PGNY) click here.